Upadacitinib | m-entrepreneurship.com

Product Name :
Upadacitinib

Search keywords :
Upadacitinib

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK1

Target Vo Short Name :
JAK1

Moa_Name:
Tyrosine-protein kinase JAK1 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2019

Origin Company_Name :
Abbvie Inc

Active Company_Name :
Abbvie Deutschland Gmbh & Co Kg

Active Indication_Name:
Polyarticular Juvenile Idiopathic Arthritis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Etrolizumab In Vitro
Filamin A Rabbit mAb supplier
Cathepsin D Antibody: Cathepsin D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45/28 kDa, targeting to Cathepsin D. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts